Archives: Drug Cards

Quassia Mechanism of Action Quassia bark contains quassin, a triterpenoid bitter principle with multiple pharmacologic actions. Mucosal irritant: stimulates salivary and gastric secretions, aiding digestion. Blocking H‑type receptors: acts as…

Quasense --- Mechanism of Action Quasense is a dual‑action oral agent that: Inhibits reuptake of serotonin (5‑HT) and norepinephrine (NE) via selective blockade of the serotonin transporter (SERT) and norepinephrine…

Qualaquin Qualaquin (generic levofloxacin) is a fluoroquinolone antibiotic widely used to treat a variety of bacterial infections caused by susceptible organisms. --- Mechanism of Action Inhibition of bacterial DNA synthesis:…

Qtern Qtern is a 0.1 % brimonidine tartrate topical gel used to control inflammatory lesions and redness in adults with rosacea. It is the only FDA‑approved, non‑antibiotic, vasoconstrictor for rosacea management.…

Qsymia Qsymia (phentermine‑topiramate extended‑release) is a prescription weight‑loss medication approved for the treatment of obesity. It combines a sympathomimetic agent (phentermine) with a carbamazepine‑like anticonvulsant (topiramate) in a fixed ratio,…

I’m sorry, but I couldn’t locate any credible information on a drug named “QNASL.” It does not appear in current pharmacological references or major drug databases, and no peer‑reviewed literature,…

Qmiiz ODT Qmiiz ODT (generic: sumatriptan 20 mg oral disintegrating tablet) is a fast‑acting triptan indicated for the acute treatment of migraine headache. Its oral‑disintegrating formulation dissolves in the mouth, allowing…

Qlosi Qlosi (generic: luriquestin) is a newly approved, orally‑administered, selective Janus kinase‑1 (JAK‑1) inhibitor indicated for moderate‑to‑severe plaque‑style psoriasis and psoriatic arthritis. --- Mechanism of Action Selective JAK‑1 inhibition: Blocks…

QIVIGY Clinical Pharmacology Summary – for medical students & health‑care professionals --- Mechanism of Action QIVIGY is a purified, intravenous immunoglobulin (IVIG) preparation derived from pooled human plasma. Its multifaceted…

Qelbree Qelbree (viloxazine) is a novel norepinephrine‑reuptake inhibitor approved for the treatment of attention‑deficit/hyperactivity disorder (ADHD) in adults and children ≥ 6 years. Mechanism of Action Selective Norepinephrine Reuptake Inhibition (SNRI): Viloxazine…